Within the BoP, the current account yielded a deficit (CAD) in the first quarter of financial year 2026-27 (Q1FY27), reversing the surplus s...Read More
US pharma tariff relief has different implications for Indian drugmakers, with generic, specialty, injectable and CDMO businesses facing dis...Read More
The factors affecting private investment may be more global in nature in the immediate future, suggested Madhavi Arora, chief economist at E...Read More
Discover how select SME-listed companies in India are achieving profit growth significantly outpacing sales growth by optimizing margins, wo...Read More
Three mid-cap companies are seeing growth accelerate, supported by rising demand, new business opportunities, stronger order visibility, and...Read More